GenoME Diagnostics Ltd

Improving the ovarian cancer diagnostic pathway through earlier and more accurate diagnosis.

Founded 2020

United Kingdom 5 employees Seed Total: $2.25M Health Care

GenoME Diagnostics Ltd is a startup focused on revolutionizing the ovarian cancer diagnostic pathway. Their slogan, "Improving the ovarian cancer diagnostic pathway through earlier and more accurate diagnosis," reflects their core mission. Founded in 2020, GenoME Diagnostics is a spinout from the renowned Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast. The company is dedicated to developing innovative blood tests for the early and precise detection of ovarian and pancreatic cancers, with the ultimate goal of reducing misdiagnosis and late detection to improve patient survival and outcomes. The most recent milestone for GenoME Diagnostics is the £500.00K grant investment they secured on 03 March 2023 from Innovate UK. This investment signifies a vote of confidence in the promising potential of their technology and approach. Furthermore, GenoME Diagnostics is not narrowly focused on ovarian and pancreatic cancers alone; rather, their pipeline holds the potential for biomarker discovery and development across various diseases and applications. This indicates a broader scope and long-term vision for their technology to have a meaningful impact beyond their initial target areas. With their headquarters in the United Kingdom, GenoME Diagnostics is poised to make significant contributions to the field of cancer diagnostics and beyond.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	£500.00K	1	Innovate UK	03 Mar 2023
Seed Round	£1.40M	3	Qubis, Deepbridge Capital +1	03 Mar 2023
Grant	£50.00K	1	Innovate UK	06 Mar 2022
Pre Seed Round	£300.00K	3	Qubis, Deepbridge Capital +1	25 May 2021

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

£500.00K

Innovate UK

03 Mar 2023

Seed Round

£1.40M

Qubis, Deepbridge Capital +1

03 Mar 2023

Grant

£50.00K

Innovate UK

06 Mar 2022

Pre Seed Round

£300.00K

Qubis, Deepbridge Capital +1

25 May 2021

FAQ About GenoME Diagnostics Ltd

Improving the ovarian cancer diagnostic pathway through earlier and more accurate diagnosis.

GenoME Diagnostics Ltd was founded in 2020.

GenoME Diagnostics Ltd is headquartered in United Kingdom.

GenoME Diagnostics Ltd operates in Health Care. Its work centres on Ovarian cancer, Diagnostic test, Biomarker discovery and Blood test.

GenoME Diagnostics Ltd has approximately 5 employees.

GenoME Diagnostics Ltd has completed 4 funding rounds, raising a total of $2.25M. The latest funding stage is Seed.

Top alternatives and competitors to GenoME Diagnostics Ltd include Beacon Biomedical, Craif Inc., Nexosome Oncology, JL MediLabs Inc., HAWK Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

GenoME Diagnostics Ltd and Beacon Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About GenoME Diagnostics Ltd

Funding Rounds & Investors (4)

GenoME Diagnostics Ltd Alternatives & Competitors

FAQ About GenoME Diagnostics Ltd